Early Development Considerations for Innovative Combination Products: Guidance for Industry and FDA Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 1, 2006
May 13, 2021
36676b52-57e2-4ab3-8bb5-0c933692434b
Related Documents
Submission and Resolution of Formal Disputes Regarding the Timeliness of Premarket Review of a Combination Product: Guidance for Industry and FDA Staff
Guidance DocumentMay 3, 2004Office of the Commissioner
New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products: Guidance for Industry
Guidance DocumentJanuary 6, 2010Office of the Commissioner
Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products: Guidance for Industry and FDA Staff
Guidance DocumentJune 7, 2013Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox